2,3-Difluorophenylboronic acid

We are 2,3-Difluorophenylboronic acid CAS:121219-16-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 2,3-Difluorophenylboronic acid
Other Name:
2,3-Difluorophenylboronic acid
2,3-Difluorobenzeneboronic Acid
(2,3-difluorophenyl)boronic acid
CAS No: 121219-16-7
MF: C6H5BF2O2
MW: 157.91100
Density: 1.35 g/cm3
Boiling point: 274.8ºC at 760 mmHg
Melting point: 95 °C (dec.)(lit.)
Flash point: 120ºC
Refractive index: 1.485
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,3-Difluorophenylboronic acid


Related News: The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.5-bromo-2-fluoro-3-methylpyridine The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.(E) -4-ácido hidroxicrotónico CAS:24587-49-3 “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”236750-65-5 “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.

Related Products
Product Name
2,3-Difluorophenylacetic acid View Details
2-Chloro-4-fluorobenzaldehyde View Details
2-(Chloromethyl)-1-fluoro-4-(trifluoromethyl)benzene View Details
4-[(4-hydroxy-6-oxo-1H-pyrimidin-2-yl)amino]benzonitrile manufacturer 2,6-Dioxopiperidine-3-ammonium chloride manufacturer 4-Methoxy-2-methylbenzoic acid manufacturer phenoxyacetic acid manufacturer 5-Chloro-1-Pentanol manufacturer